These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 6781440)

  • 1. [Electrophysiologic properties of intravenous labetalol in normotensive and hypertensive patients].
    Clémenty J; Dallocchio M; Bricaud H
    Arch Mal Coeur Vaiss; 1981 Jan; 74(1):65-71. PubMed ID: 6781440
    [No Abstract]   [Full Text] [Related]  

  • 2. Acute effect of intravenous labetalol in the treatment of systemic arterial hypertension.
    Ronne-Rasmussen JO; Andersen GS; Jensen NB; Andersson E
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):805-8. PubMed ID: 990157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hemodynamic study of a new injectable anti-hypertensive: labetalol].
    Clementy J; Dallocchio M
    Nouv Presse Med; 1978 Dec; 7(43):3934. PubMed ID: 733550
    [No Abstract]   [Full Text] [Related]  

  • 4. [Effects of labetalol on the response of arterial blood pressure to exercise in hypertensive patients].
    Wajngarten M; Antunes JE; Pereyra PL; Godoy M; Dauar D; Martinelli Filho M; Pereira Barretto AC; Pileggi F
    Arq Bras Cardiol; 1983 Jan; 40(1):65-7. PubMed ID: 6615264
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute and long-term effects of labetalol on systemic and pulmonary haemodynamics in hypertensive patients.
    Svendsen TL; Rasmussen S; Hartling OJ; Nielsen PE; Trap-Jensen J
    Eur J Clin Pharmacol; 1980 Jan; 17(1):5-11. PubMed ID: 7371699
    [No Abstract]   [Full Text] [Related]  

  • 6. Immediate effects of labetalol on central, splanchnic-hepatic, and forearm haemodynamics during pleasant emotional stress in hypertensive patients.
    Trap-Jensen J; Clausen JP; Hartling OJ; Svendsen TL; Krogsgaard AR
    Postgrad Med J; 1980; 56 Suppl 2():37-42. PubMed ID: 7433341
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of labetalol on plasma catecholamines at rest and during increased sympathetic activity.
    Carlsen JE; Trap-Jensen J; Svendsen TL; Nielsen PE; Rasmussen S; Christensen NJ
    Postgrad Med J; 1980; 56 Suppl 2():43-8. PubMed ID: 7433342
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of labetalol as a moderate hypotensive agent in otological operations--plasma concentrations after intravenous administration.
    Kanto J; Pakkanen A; Allonen H; Kleimola T; Mäntylä R
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):191-4. PubMed ID: 7390669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute hemodynamic effects of labetalol in severe hypertension.
    Omvik P; Lund-Johansen P
    J Cardiovasc Pharmacol; 1982; 4(6):915-20. PubMed ID: 6185782
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Antihypertensive effects of labetalol administered parenterally and orally].
    Nicolaescu V; Serban-Pârâu G; Ionescu P; Nuţă M
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1984; 36(5):405-12. PubMed ID: 6151227
    [No Abstract]   [Full Text] [Related]  

  • 11. [Effect of intravenous labetalol on hemodynamics and myocardial metabolism in coronary insufficiency].
    Lardoux H; Ourbak P; Pornin M; Duong TC; Chouty F; Maurice P
    Therapie; 1983; 38(2):149-54. PubMed ID: 6636022
    [No Abstract]   [Full Text] [Related]  

  • 12. I.V. Labetalol during coronary artery surgery.
    Joucken K
    Acta Anaesthesiol Belg; 1983; 34(1):15-26. PubMed ID: 6845955
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Therapy of hypertensive crises with a mono-substance with alpha- and beta-blocking properties (labetalol)].
    Holzer H; Pogglitsch H; Katschnig H; Korthals C
    Wien Med Wochenschr Suppl; 1981; 69():10-3. PubMed ID: 6952657
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Successful treatment of a monoamine oxidase inhibitor-tyramine hypertensive emergency with intravenous labetalol.
    Abrams JH; Schulman P; White WB
    N Engl J Med; 1985 Jul; 313(1):52. PubMed ID: 4000229
    [No Abstract]   [Full Text] [Related]  

  • 15. [Use of labetalol in the treatment of hypertensive crises].
    Semplicini A; Pessina AC; Rossi GP; Palatini P; Hlede M; Morandin F; Visonà A; Mazzucato A; Dal Palù C
    G Ital Cardiol; 1982; 12(5):355-8. PubMed ID: 7152187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rate of onset of hypotensive response with oral labetalol [proceedings].
    Breckenridge AM; Macnee CM; Orme NL; Richards DA; Sterlin MJ
    Br J Clin Pharmacol; 1977 Jun; 4(3):388P. PubMed ID: 901712
    [No Abstract]   [Full Text] [Related]  

  • 17. [Essential arterial hypertension. Effects of labetalol on blood pressure and renin-angiotensin system (author's transl)].
    Martinand A; Lardoux H; Corvol P; Milliez P
    Nouv Presse Med; 1980 Sep; 9(35):2565-8. PubMed ID: 7001349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Cardiovascular effects of acute administration of labetalol in hypertensive patients].
    Novo S; Pinto A; Davì G; Riolo F; Gullotti D
    Boll Soc Ital Cardiol; 1980; 25(2):149-56. PubMed ID: 7016144
    [No Abstract]   [Full Text] [Related]  

  • 19. Haemodynamic effects of intravenous labetalol in hypertensive patients with obstructive coronary heart disease complicated by acute myocardial infarction of recent origin.
    Mulac KD; Meryn S
    Eur Heart J; 1983 Jun; 4(6):398-405. PubMed ID: 6617686
    [No Abstract]   [Full Text] [Related]  

  • 20. Sequential haemodynamic effects of labetalol at rest and during exercise in essential hypertension.
    Svendsen TL; Rasmussen S; Hartling OJ; Nielsen PE; Trap-Jensen J
    Postgrad Med J; 1980; 56 Suppl 2():21-6. PubMed ID: 7433338
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.